Beer-Sheva, Israel

Eleonora Shaubi

USPTO Granted Patents = 1 


 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Eleonora Shaubi: Innovator in Amphiphilic Compounds and Drug Targeting

Introduction

Eleonora Shaubi is a prominent inventor based in Beer-Sheva, Israel. She has made significant contributions to the field of drug delivery systems through her innovative research on amphiphilic compounds. Her work focuses on creating targeted therapies that can improve the efficacy of treatments for various medical conditions.

Latest Patents

Eleonora holds a patent for "Amphiphilic compounds and vesicles liposomes for organ-specified drug targeting." This patent describes an amphiphilic compound capable of forming vesicles or liposomes. The compound features at least one headgroup containing a selectively cleavable group, which can be cleaved under specific conditions, such as changes in the chemical, physical, or biological environment. This technology is particularly useful for delivering therapeutic substances or diagnostic agents specifically to target organs or tissues, as well as for gene therapy applications. She has 1 patent to her name.

Career Highlights

Eleonora is affiliated with the Ben-Gurion University of the Negev Research and Development Authority. Her work at this institution has allowed her to explore innovative solutions in drug delivery and contribute to advancements in medical research.

Collaborations

Some of her notable coworkers include Eliahu Heldman and Charles Linder. Their collaborative efforts have further enhanced the research and development of amphiphilic compounds and their applications in medicine.

Conclusion

Eleonora Shaubi's contributions to the field of drug targeting through her innovative research on amphiphilic compounds highlight her role as a leading inventor. Her work has the potential to significantly impact therapeutic delivery systems and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…